| Dr Paul T Adams, MD | |
|
302 Kensington Ave, Flint, MI 48503-2044 | |
| (810) 762-8200 | |
| (810) 762-8202 |
| Full Name | Dr Paul T Adams |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 39 Years |
| Location | 302 Kensington Ave, Flint, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811952591 | NPI | - | NPPES |
| 104396721 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 4301050024 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Genesys Regional Medical Center - Health Park | Grand blanc, MI | Hospital |
| Hurley Medical Center | Flint, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Genesee Hematology-oncology, P.c. | 1153451265 | 4 |
News Archive
Recondo Technology, a leading provider of revenue cycle solutions for the healthcare industry, announced today that Recondo has become an Organizational Member of Health Level Seven® International, the global authority on standards for interoperability of health information technology. Health Level Seven has members in over 55 countries. The Health Level Seven (HL7) vision is to create the best and most widely used standards in healthcare.
Optibrium and ChemAxon, developers of software and cheminformatics solutions for drug discovery, today announced the results of a collaboration to integrate ChemAxon's Plexus with Optibrium's StarDrop software suite. The integration of these platforms further enables researchers to develop strategies for efficient, high quality compound library design.
An artificial intelligence tool accurately predicted which patients newly infected with the COVID-19 virus would go on to develop severe respiratory disease, a new study found.
The International Myeloma Foundation (IMF)—supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians—today said presentations at the annual meeting of the American Society of Hematology (ASH) will cover all stages of multiple myeloma, a major milestone in treating this and related cancers.
Today the Drugs for Neglected Diseases initiative (DNDi) in Latin America received the Carlos Slim Health Award for 10 years of exceptional work and achievements in research and development (R&D) to deliver new treatments for neglected patients in the region. The $100,000 award will be presented at a ceremony in April in Mexico City.
› Verified 4 days ago
| Entity Name | Hurley Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982630844 PECOS PAC ID: 2961308481 Enrollment ID: O20031208000375 |
News Archive
Recondo Technology, a leading provider of revenue cycle solutions for the healthcare industry, announced today that Recondo has become an Organizational Member of Health Level Seven® International, the global authority on standards for interoperability of health information technology. Health Level Seven has members in over 55 countries. The Health Level Seven (HL7) vision is to create the best and most widely used standards in healthcare.
Optibrium and ChemAxon, developers of software and cheminformatics solutions for drug discovery, today announced the results of a collaboration to integrate ChemAxon's Plexus with Optibrium's StarDrop software suite. The integration of these platforms further enables researchers to develop strategies for efficient, high quality compound library design.
An artificial intelligence tool accurately predicted which patients newly infected with the COVID-19 virus would go on to develop severe respiratory disease, a new study found.
The International Myeloma Foundation (IMF)—supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians—today said presentations at the annual meeting of the American Society of Hematology (ASH) will cover all stages of multiple myeloma, a major milestone in treating this and related cancers.
Today the Drugs for Neglected Diseases initiative (DNDi) in Latin America received the Carlos Slim Health Award for 10 years of exceptional work and achievements in research and development (R&D) to deliver new treatments for neglected patients in the region. The $100,000 award will be presented at a ceremony in April in Mexico City.
› Verified 4 days ago
| Entity Name | Genesee Hematology-oncology, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902977101 PECOS PAC ID: 1153451265 Enrollment ID: O20100616000923 |
News Archive
Recondo Technology, a leading provider of revenue cycle solutions for the healthcare industry, announced today that Recondo has become an Organizational Member of Health Level Seven® International, the global authority on standards for interoperability of health information technology. Health Level Seven has members in over 55 countries. The Health Level Seven (HL7) vision is to create the best and most widely used standards in healthcare.
Optibrium and ChemAxon, developers of software and cheminformatics solutions for drug discovery, today announced the results of a collaboration to integrate ChemAxon's Plexus with Optibrium's StarDrop software suite. The integration of these platforms further enables researchers to develop strategies for efficient, high quality compound library design.
An artificial intelligence tool accurately predicted which patients newly infected with the COVID-19 virus would go on to develop severe respiratory disease, a new study found.
The International Myeloma Foundation (IMF)—supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians—today said presentations at the annual meeting of the American Society of Hematology (ASH) will cover all stages of multiple myeloma, a major milestone in treating this and related cancers.
Today the Drugs for Neglected Diseases initiative (DNDi) in Latin America received the Carlos Slim Health Award for 10 years of exceptional work and achievements in research and development (R&D) to deliver new treatments for neglected patients in the region. The $100,000 award will be presented at a ceremony in April in Mexico City.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul T Adams, MD 302 Kensington Ave, Flint, MI 48503-2044 Ph: (810) 762-8200 | Dr Paul T Adams, MD 302 Kensington Ave, Flint, MI 48503-2044 Ph: (810) 762-8200 |
News Archive
Recondo Technology, a leading provider of revenue cycle solutions for the healthcare industry, announced today that Recondo has become an Organizational Member of Health Level Seven® International, the global authority on standards for interoperability of health information technology. Health Level Seven has members in over 55 countries. The Health Level Seven (HL7) vision is to create the best and most widely used standards in healthcare.
Optibrium and ChemAxon, developers of software and cheminformatics solutions for drug discovery, today announced the results of a collaboration to integrate ChemAxon's Plexus with Optibrium's StarDrop software suite. The integration of these platforms further enables researchers to develop strategies for efficient, high quality compound library design.
An artificial intelligence tool accurately predicted which patients newly infected with the COVID-19 virus would go on to develop severe respiratory disease, a new study found.
The International Myeloma Foundation (IMF)—supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians—today said presentations at the annual meeting of the American Society of Hematology (ASH) will cover all stages of multiple myeloma, a major milestone in treating this and related cancers.
Today the Drugs for Neglected Diseases initiative (DNDi) in Latin America received the Carlos Slim Health Award for 10 years of exceptional work and achievements in research and development (R&D) to deliver new treatments for neglected patients in the region. The $100,000 award will be presented at a ceremony in April in Mexico City.
› Verified 4 days ago
Vidya Sagar Kollu, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: G3230 Beecher Rd, Suite 2, Flint, MI 48532 Phone: 810-342-5800 Fax: 810-342-5810 | |
Dr. Mohamad Monir Khoulani, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5080 Villa Linde Pkwy, Unit 4, Flint, MI 48532 Phone: 810-720-5440 Fax: 810-720-4670 | |
Russell Diponio, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4444 W Bristol Rd Ste 150, Flint, MI 48507 Phone: 810-230-9500 Fax: 810-230-0169 | |
Muhammad Bakleh, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5040 Villa Linde Pkwy, Flint, MI 48532 Phone: 810-230-0788 | |
Dr. Haymanot Y Gebre, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: G3230 Beecher Rd Ste 2, Flint, MI 48532 Phone: 810-342-5800 Fax: 810-342-5810 | |
Dr. Donald J Hardman, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3499 S Linden Rd Ste 2, Flint, MI 48507 Phone: 810-820-8121 Fax: 810-820-8335 | |
Hameem Changezi, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5084 Villa Linde Pkwy, Suite 6, Flint, MI 48532 Phone: 810-600-3399 Fax: 810-600-3398 |